Quantum Financial Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$876K Buy
3,480
+89
+3% +$19.1K 0.09% 86
2026
Q1
$737K Sell
3,391
-201
-6% -$44.6K 0.08% 82
2025
Q4
$821K Buy
3,592
+106
+3% +$24.1K 0.09% 80
2025
Q3
$807K Buy
3,486
+5
+0.1% +$1.02K 0.1% 76
2025
Q2
$646K Buy
3,481
+3
+0.1% +$558 0.09% 83
2025
Q1
$729K Sell
3,478
-113
-3% -$22K 0.11% 78
2024
Q4
$638K Sell
3,591
-46
-1% -$8.46K 0.1% 77
2024
Q3
$718K Sell
3,637
-75
-2% -$14K 0.11% 76
2024
Q2
$637K Buy
3,712
+41
+1% +$6.79K 0.11% 75
2024
Q1
$668K Buy
3,671
+1,005
+38% +$173K 0.12% 74
2023
Q4
$413K Buy
2,666
+36
+1% +$5.25K 0.1% 60
2023
Q3
$392K Sell
2,630
-4
-0.2% -$587 0.12% 63
2023
Q2
$355K Sell
2,634
-88
-3% -$12.9K 0.1% 58
2023
Q1
$434K Buy
2,722
+5
+0.2% +$764 0.14% 46
2022
Q4
$439K Buy
2,717
+122
+5% +$18.7K 0.2% 38
2022
Q3
$348K Buy
2,595
+3
+0.1% +$430 0.15% 43
2022
Q2
$365K Buy
+2,592
New +$396K 0.14% 47

Other funds holding ABBV

Quantum Financial Advisors's ABBV Position: Q2 2026 in Review

Quantum Financial Advisors increased its AbbVie (ABBV) stake by 2.6% in Q2 2026, buying an estimated $19.1K and bringing the position to 3,480 shares worth $876K. The position accounts for 0.09% of the portfolio, ranked #86.

Quantum Financial Advisors first reported a position in ABBV in Q2 2022 and has held it in 17 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Quantum Financial Advisors held 3,480 shares of AbbVie worth $876K as of Q2 2026.
  • Quantum Financial Advisors bought 89 AbbVie shares in Q2 2026, an estimated $19.1K.
  • AbbVie made up 0.09% of Quantum Financial Advisors's portfolio in Q2 2026, its #86 holding.
  • Quantum Financial Advisors first reported a position in AbbVie in Q2 2022 and has held it in 17 quarters since.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Quantum Financial Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.